the aid library

LIST OPTIONS

Filter

5634

Chemical Weapons: A Summary Report of Characteristics and Effects

Shea, DA Congressional Research Service (2013) C2

The potential for terrorist use of chemical agents is a noted concern highlighted by the Tokyo sarin gas attacks of 1995. The events of September 11, 2001, increased congressional attention towards reducing the vulnerability of the United States to such unconventional attacks. The possibility that... more

Download (461)

View PDF (646)

WHO recommendation on duration of bladder catheterization after surgical repair of simple obstetric urinary fistula

World Health Organization WHO (2018) C_WHO

WHO has issued a new recommendation on the length of bladder catheterization following surgical repair of a simple obstetric urinary fistula. Currently the length of catheterization is not standard and ranges from 5 to 42 days. The new guidance recommends a 7–10 day period of bladder catheterizati... more

Download (359)

View PDF (495)

Collaborative framework for addressing Autism Spectrum Disorder in the South-East Asia Region

World Health Organization (WHO), Regional Office for South-East-Asia (2017) C_WHO

Based on WHO South-East Asia Regional Strategy on Autism Spectrum Disorder
The collaborative framework for implementation of the “WHO South-East Asia Regional Strategy on Autism Spectrum Disorders” articulates to Member States: the nature of autism spectrum disorder and the issues faced by ... more

Download (209)

View PDF (347)

Provision of Primary Healthcare among Internally Displaced Persons and Vulnerable Populations of Burma

Back Pack Health Worker Team (BPHWT) (2016) C1

Project Programs:
A. Medical Care Program
B. Community Health Promotion and Prevention Program
C. Maternal and Child Health Program
Target Population: 228,000 people living within the Mon, Kayah, Kayan, Karen,Shan, Kachin, Pa O, Chin and Arakan areas
Projec...t Duration:January to December 2016 more

Download (340)

View PDF (466)

Uterotonics for the prevention of postpartum haemorrhage
recommended

World Health Organization WHO (2018) C_WHO

WHO Recommendations 2018 Update The primary audience for these recommendations includes health professionals who are responsible for developing national and local health care guidelines and protocols (particularly those related to PPH prevention and treatment) and those involved in the provision of... more

Download (137)

View PDF (150)

SARS-CoV-2 antigen-detecting rapid diagnostic tests: An implementation guide

World Health Organization WHO (2021) C_WHO

This guide provides an overview of the major elements that must be considered before, during and after the implementation of antigen-detecting rapid diagnostic tests (Ag-RDTs) for SARS-CoV-2. This guide is complementary to policy guidance issued by the World Health Organization (WHO). The guide may ... more

Download (121)

View PDF (168)

Point-of-use fortification with micronutrient powders (mnp)improving the nutrition of infants and young children aged 6-23 months (Healthcare Providers)

Ministry of Health, Kenya (2020) C1

The micronutrient powders will be distributed at the health facilities where instructions on use will be provided by Health Care Providers. Community Health Volunteers will educate, counsel, and mobilize caregivers at the community level to visit health facilities for nutrition assessment and provis... more

Download (194)

View PDF (245)

Interregional meeting on leishmaniasis among neighbouring endemic countries in the Eastern Mediterranean, African and European regions

World Health Organization WHO (2019) C_WHO

An interregional meeting on leishmaniasis among neighbouring endemic countries in the Eastern Mediterranean, African and European regions was organized by the World Health Organization (WHO) Regional Office for the Eastern Mediterranean in Amman, Jordan, from 23 to 25 September 2018. The meeting w... more

Download (176)

View PDF (164)

WHO report on the global tobacco epidemic, 2023: protect people from tobacco smoke

World Health Organisation (WHO) (2023) C_WHO

The ninth WHO report on the global tobacco epidemic tracks the progress made by countries in tobacco control since 2008 and, marks 15 years since the introduction of the MPOWER technical package which is designed to help countries implement the demand-reduction measures of the WHO Framework Conventi... more

Download (285)

View PDF (384)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

WHO competency framework, risk communication and community engagement

World Health Organization WHO (2024) C_WHO

The risk communication and community engagement (RCCE) competency framework is a resource that details the essential behaviours and activities necessary for effective communication and engagement with communities before, during and after public health emergencies. The purpose of this framework is to... more

Towards a dementia inclusive society

World Health Organization WHO (2021) C_WHO

The toolkit provides practical guidance and tools that can support efforts, including planning and implementation activities, to create dementia-inclusive societies. The toolkit is divided into two parts. Part I contains background information and a conceptual framework for creating dementia-incl... more

Download (170)

View PDF (229)

Caregiver skills training for families of children with developmental delays or disabilities - Home visit guide for facilitators

World Health Organization WHO (2022) C_WHO

This guide is part of a five-part Caregiver skills training for families of children with developmental delays or disabilities (CST) package providing guidance on caregiver skills training for families of children aged 2–9 years with developmental delays or disabilities. This guide for facilita... more

External Link

iSupport
recommended

World Health Organization WHO (2022) C_WHO

iSupport is a self-help skills and training programme for carers of people with dementia. Worldwide, around 55 million people have dementia. Dementia causes significant psychological and emotional impact on families and carers. iSupport aims to prevent and/or decrease mental and physical health prob... more

Download (182)

View PDF (197)

Questions and answers on the prevention and control of alcohol-related harm

World Health Organization, Regional Office for the Western Pacific (2019) C_WHO

The "Questions and Answers on Prevention and control of Alcohol related harm" has been developed by WHO country office in Viet Nam with technical contribution from national and international experts in the field. This publication provides scientific evidences on harms of alcohol use to the health of... more

Interactive Atlas of Leishmaniasis in the Americas: Clinical Aspects and Differential Diagnosis

Pan American Health Organisation PAHO (2021) C_WHO

In the Region of the Americas, the leishmaniases are a group of diseases caused by various species of Leishmania, which cause a set of clinical syndromes in infected humans that can involve the skin, mucosa, and visceral organs. The spectrum of clinical disease is varied and depends on the interacti... more

WHO recommendations on induction of labour, at or beyond term

World Health Organization WHO (2022) C_WHO

The primary audience for these recommendations includes health professionals who are responsible for developing national and local health-care guidelines and protocols and health workers involved in the provision of care to women and their newborns during pregnancy, labour and childbirth; this inclu... more

WHO recommendations on mechanical methods for induction of labour

World Health Organization WHO (2022) C_WHO

Download (1238)

View PDF (2023)

Sanitation Safety Planning

World Health Organization WHO (2022) C_WHO

Manual for step-by-step risk management for safely managed sanitation systems. 2nd edition. This Sanitation safety planning (SSP) manual provides practical, step-by-step guidance to assist in the implementation of the 2018 World Health Organization (WHO) Guidelines on sanitation and health and the ... more

Download (414)

View PDF (496)

Developing drinking-water quality regulations and standards: general guidance with a special focus on countries with limited resources

World Health Organization (WHO) (2018) CC

Drinking-water quality regulations and standards developed or revised in accordance with this guidance will reflect the best practices identified in the WHO Guidelines for Drinking-water Quality to most effectively protect public health. Moreover, the regulations and standards will consider local ne... more

Uterotonics for the prevention of postpartum haemorrhage recommended

iSupport recommended

Uterotonics for the prevention of postpartum haemorrhage
recommended

iSupport
recommended